Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Clin Oncol (R Coll Radiol)
; 35(5): 301-310, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36732121
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Radiotherapy, Intensity-Modulated
/
Proton Therapy
Type of study:
Health_economic_evaluation
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Clin Oncol (R Coll Radiol)
Journal subject:
NEOPLASIAS
Year:
2023
Type:
Article